Symbols / MED Stock $12.59 +0.88% Medifast, Inc.

Consumer Cyclical • Personal Services • United States • NYQ
MED (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Cyclical
Industry Personal Services
CEO Mr. Daniel R. Chard
Exch · Country NYQ · United States
Market Cap 139.99M
Enterprise Value -23.76M
Income -20.02M
Sales 346.10M
FCF (ttm) 4.41M
Book/sh 19.29
Cash/sh 16.48
Employees 380
Insider 10d —
IPO Dec 30, 1993
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -20.98
PEG 0.97
P/S 0.40
P/B 0.65
P/C —
EV/EBITDA 5.96
EV/Sales -0.07
Quick Ratio 4.00
Current Ratio 4.80
Debt/Eq 8.14
LT Debt/Eq —
EPS (ttm) -1.82
EPS next Y -0.60
EPS Growth —
Revenue Growth -34.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-04
Earnings (prior) 2026-05-04
ROA -4.33%
ROE -9.80%
ROIC —
Gross Margin 70.12%
Oper. Margin -7.21%
Profit Margin -5.79%
Shs Outstand 11.12M
Shs Float 8.46M
Insider Own 3.88%
Instit Own 77.30%
Short Float 18.93%
Short Ratio 10.51
Short Interest 2.03M
52W High 15.46
vs 52W High -18.56%
52W Low 9.22
vs 52W Low 36.55%
Beta 0.57
Impl. Vol. 25.00%
Rel Volume 0.48
Avg Volume 253.82K
Volume 122.94K
Target (mean) $12.00
Tgt Median $12.00
Tgt Low $12.00
Tgt High $12.00
# Analysts 1
Recom Hold
Prev Close $12.48
Price $12.59
Change 0.88%
About

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$12.00
Mean price target
2. Current target
$12.59
Latest analyst target
3. DCF / Fair value
$7.14
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$12.59
Low
$12.00
High
$12.00
Mean
$12.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-19 main Stephens & Co. Equal-Weight → Equal-Weight $12
2025-02-19 main DA Davidson Neutral → Neutral $17
2024-11-05 up DA Davidson Underperform → Neutral $17
2024-07-22 main DA Davidson Underperform → Underperform $18
2024-06-05 down DA Davidson Neutral → Underperform $18
2024-04-30 main DA Davidson Neutral → Neutral $25
2024-02-21 main DA Davidson Neutral → Neutral $40
2023-10-13 init Stephens & Co. — → Equal-Weight $82
2023-08-08 main DA Davidson Neutral → Neutral $80
2023-07-31 main DA Davidson Neutral → Neutral $93
2023-05-02 main DA Davidson — → Neutral $71
2023-02-22 main DA Davidson — → Neutral $94
2022-11-04 down DA Davidson Buy → Neutral $106
2022-08-04 main DA Davidson — → Buy $278
2022-08-04 down Jefferies Buy → Hold $150
2022-06-02 main DA Davidson — → Buy $352
2022-02-24 main DA Davidson — → Buy $341
2021-11-08 main DA Davidson — → Buy $349
2021-05-05 main DA Davidson — → Buy $395
2021-02-26 main DA Davidson — → Buy $302
News
RSS: Latest MED news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-11 SCHLACKMAN SCOTT Director — 5,000 $12.53 $62,950
2026-03-25 MALONEY JAMES P. Chief Financial Officer — 35,358 $0.00 $0
2026-03-25 MACKENZIE JONATHAN BARRETT Officer — 10,830 $0.00 $0
2026-03-25 CHARD DANIEL R Chief Executive Officer — 41,795 $0.00 $0
2026-03-20 CHARD DANIEL R Chief Executive Officer — 17,678 $10.11 $178,725
2025-06-25 HOER MICHAEL A. Director — 11,168 $0.00 $0
2025-06-25 THOMAS ANDREA B Director — 11,168 $0.00 $0
2025-06-25 GEARY ELIZABETH A. Director — 11,168 $0.00 $0
2025-06-25 BROWN JEFFREY J. Director — 20,617 $0.00 $126,528
2025-06-25 SCHLACKMAN SCOTT Director — 11,168 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
385.79
-35.96%
602.46
-43.80%
1,072.05
-32.94%
1,598.58
Operating Revenue
385.79
-35.96%
602.46
-43.80%
1,072.05
-32.94%
1,598.58
Cost Of Revenue
110.60
-29.93%
157.84
-46.71%
296.20
-35.35%
458.16
Reconciled Cost Of Revenue
110.60
-29.93%
157.84
-46.71%
296.20
-35.35%
458.16
Gross Profit
275.19
-38.11%
444.62
-42.69%
775.85
-31.97%
1,140.41
Operating Expense
289.40
-34.49%
441.75
-31.98%
649.45
-32.04%
955.61
Selling General And Administration
289.40
-34.49%
441.75
-31.98%
649.45
-32.04%
955.61
Total Expenses
400.00
-33.29%
599.59
-36.60%
945.65
-33.11%
1,413.77
Operating Income
-14.21
-593.85%
2.88
-97.72%
126.40
-31.60%
184.81
Total Operating Income As Reported
-14.21
-593.85%
2.88
-97.72%
126.40
-31.60%
184.81
EBITDA
0.03
-99.81%
15.59
-88.83%
139.51
-28.73%
195.74
Normalized EBITDA
0.03
-99.81%
15.59
-88.83%
139.51
-28.73%
195.74
Reconciled Depreciation
14.24
+12.08%
12.71
-3.05%
13.11
+19.37%
10.98
EBIT
-14.21
-593.85%
2.88
-97.72%
126.40
-31.59%
184.76
Net Income
-18.67
-992.97%
2.09
-97.90%
99.42
-30.75%
143.57
Pretax Income
-5.64
-248.90%
3.79
-97.06%
128.80
-30.02%
184.06
Net Non Operating Interest Income Expense
5.52
+14.82%
4.80
+92.93%
2.49
+455.21%
-0.70
Interest Expense Non Operating
—
—
—
0.70
Net Interest Income
5.52
+14.82%
4.80
+92.93%
2.49
+455.21%
-0.70
Interest Expense
—
—
—
0.70
Interest Income Non Operating
5.52
+14.82%
4.80
+92.93%
2.49
—
Interest Income
5.52
+14.82%
4.80
+92.93%
2.49
—
Other Income Expense
3.06
+178.51%
-3.90
-4000.00%
-0.10
-106.52%
-0.05
Other Non Operating Income Expenses
3.06
+178.51%
-3.90
-4000.00%
-0.10
-106.52%
-0.05
Tax Provision
13.03
+668.46%
1.70
-94.23%
29.38
-27.44%
40.49
Tax Rate For Calcs
0.00
+0.00%
0.00
-7.89%
0.00
+3.64%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-18.67
-992.97%
2.09
-97.90%
99.42
-30.75%
143.57
Net Income From Continuing Operation Net Minority Interest
-18.67
-992.97%
2.09
-97.90%
99.42
-30.75%
143.57
Net Income From Continuing And Discontinued Operation
-18.67
-992.97%
2.09
-97.90%
99.42
-30.75%
143.57
Net Income Continuous Operations
-18.67
-992.97%
2.09
-97.90%
99.42
-30.75%
143.57
Normalized Income
-18.67
-992.97%
2.09
-97.90%
99.42
-30.75%
143.57
Net Income Common Stockholders
-18.67
-992.97%
2.09
-97.90%
99.42
-30.75%
143.57
Diluted EPS
—
0.19
-97.91%
9.10
-28.52%
12.73
Basic EPS
—
0.19
-97.91%
9.10
-29.02%
12.82
Basic Average Shares
—
10.93
+0.42%
10.88
-2.78%
11.20
Diluted Average Shares
—
10.96
+0.38%
10.92
-3.15%
11.28
Diluted NI Availto Com Stockholders
-18.67
-992.97%
2.09
-97.90%
99.42
-30.75%
143.57
Total Other Finance Cost
—
—
—
0.70
Line Item Trend 2023-12-31 2022-12-31
Total Assets
309.91
-1.99%
316.21
Current Assets
224.03
+0.56%
222.78
Cash Cash Equivalents And Short Term Investments
150.04
+71.10%
87.69
Cash And Cash Equivalents
94.44
+7.70%
87.69
Cash Equivalents
5.66
—
Cash Financial
88.78
+1.24%
87.69
Other Short Term Investments
55.60
0.00
Inventory
54.59
-54.07%
118.86
Raw Materials
7.94
-37.30%
12.67
Finished Goods
46.95
-55.88%
106.41
Prepaid Assets
19.40
0.00
Other Current Assets
10.67
-34.29%
16.24
Total Non Current Assets
85.88
-8.08%
93.43
Net PPE
67.11
-11.28%
75.64
Gross PPE
114.42
-1.01%
115.59
Accumulated Depreciation
-47.31
-18.44%
-39.94
Properties
0.00
0.00
Land And Improvements
0.56
+0.00%
0.56
Buildings And Improvements
24.50
-5.43%
25.91
Machinery Furniture Equipment
73.71
+4.32%
70.66
Other Properties
15.64
-15.25%
18.46
Non Current Deferred Assets
4.12
-22.73%
5.33
Non Current Deferred Taxes Assets
4.12
-22.73%
5.33
Other Non Current Assets
14.65
+17.61%
12.46
Total Liabilities Net Minority Interest
108.43
-32.72%
161.17
Current Liabilities
92.30
-34.49%
140.89
Payables And Accrued Expenses
85.84
-32.81%
127.76
Payables
63.73
-38.68%
103.94
Accounts Payable
39.19
-26.22%
53.12
Other Payable
13.28
-43.82%
23.63
Dividends Payable
1.41
-92.84%
19.64
Current Accrued Expenses
22.11
-7.20%
23.82
Total Tax Payable
9.86
+30.63%
7.55
Income Tax Payable
0.00
-100.00%
0.43
Current Debt And Capital Lease Obligation
5.88
+1.89%
5.78
Current Capital Lease Obligation
5.88
+1.89%
5.78
Current Deferred Liabilities
0.57
-92.20%
7.36
Current Deferred Revenue
0.57
-92.20%
7.36
Total Non Current Liabilities Net Minority Interest
16.13
-20.46%
20.27
Long Term Debt And Capital Lease Obligation
16.13
-20.46%
20.27
Long Term Capital Lease Obligation
16.13
-20.46%
20.27
Stockholders Equity
201.48
+29.95%
155.04
Common Stock Equity
201.48
+29.95%
155.04
Capital Stock
0.01
+0.00%
0.01
Common Stock
0.01
+0.00%
0.01
Share Issued
10.90
-0.28%
10.93
Ordinary Shares Number
10.90
+0.21%
10.87
Treasury Shares Number
0.00
-100.00%
0.05
Additional Paid In Capital
26.57
+23.28%
21.55
Retained Earnings
174.65
+24.88%
139.85
Gains Losses Not Affecting Retained Earnings
0.25
+933.33%
0.02
Treasury Stock
0.00
-100.00%
6.40
Other Equity Adjustments
0.25
+933.33%
0.02
Total Equity Gross Minority Interest
201.48
+29.95%
155.04
Total Capitalization
201.48
+29.95%
155.04
Working Capital
131.73
+60.86%
81.89
Invested Capital
201.48
+29.95%
155.04
Total Debt
22.01
-15.50%
26.05
Capital Lease Obligations
22.01
-15.50%
26.05
Net Tangible Assets
201.48
+29.95%
155.04
Tangible Book Value
201.48
+29.95%
155.04
Inventories Adjustments Allowances
-2.27
+40.96%
-3.84
Other Inventories
1.96
-45.67%
3.61
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
6.86
-71.96%
24.48
-83.42%
147.66
-24.11%
194.57
Cash Flow From Continuing Operating Activities
6.86
-71.96%
24.48
-83.42%
147.66
-24.11%
194.57
Net Income From Continuing Operations
-18.67
-992.97%
2.09
-97.90%
99.42
-30.75%
143.57
Depreciation Amortization Depletion
14.24
+12.08%
12.71
-3.05%
13.11
+19.37%
10.98
Depreciation And Amortization
14.24
+12.08%
12.71
-3.05%
13.11
+19.37%
10.98
Other Non Cash Items
4.62
-71.42%
16.18
+251.18%
4.61
-24.45%
6.10
Stock Based Compensation
7.64
+3.75%
7.36
-10.08%
8.19
-25.92%
11.05
Deferred Tax
11.46
+254.80%
-7.40
-711.31%
1.21
+231.06%
-0.92
Deferred Income Tax
11.46
+254.80%
-7.40
-711.31%
1.21
+231.06%
-0.92
Operating Gains Losses
-1.94
-32183.33%
-0.01
-100.51%
1.17
-44.98%
2.13
Gain Loss On Investment Securities
-3.31
-3384.21%
-0.10
—
—
Unrealized Gain Loss On Investment Securities
-0.02
-100.42%
4.09
+2826.00%
-0.15
0.00
Gain Loss On Sale Of PPE
1.37
+1442.70%
0.09
-92.41%
1.17
-44.98%
2.13
Change In Working Capital
-9.80
-0.62%
-9.74
-148.06%
20.28
-6.35%
21.65
Change In Inventory
22.19
+82.36%
12.17
-81.06%
64.27
+5.03%
61.19
Change In Prepaid Assets
0.57
-76.81%
2.47
-55.61%
5.57
+5639.18%
0.10
Change In Payables And Accrued Expense
-23.91
+31.67%
-34.99
+2.00%
-35.71
+5.02%
-37.59
Change In Payable
-23.91
+31.67%
-34.99
+2.00%
-35.71
+5.02%
-37.59
Change In Account Payable
-23.91
+31.67%
-34.99
+2.00%
-35.71
+5.02%
-37.59
Change In Other Working Capital
-6.60
-164.64%
10.21
+211.55%
-9.15
-766.79%
1.37
Change In Other Current Assets
-2.06
-619.44%
0.40
+108.44%
-4.69
-37.57%
-3.41
Investing Cash Flow
-7.93
+70.11%
-26.52
+56.56%
-61.05
-434.84%
-11.41
Cash Flow From Continuing Investing Activities
-7.93
+70.11%
-26.52
+56.56%
-61.05
-434.84%
-11.41
Net PPE Purchase And Sale
-5.61
+24.68%
-7.45
-14.98%
-6.48
+61.14%
-16.68
Purchase Of PPE
-5.61
+24.68%
-7.45
-14.98%
-6.48
+61.14%
-16.68
Capital Expenditure
-5.61
+24.68%
-7.45
-14.98%
-6.48
+61.14%
-16.68
Net Investment Purchase And Sale
-2.31
+87.86%
-19.07
+65.06%
-54.56
-1135.96%
5.27
Purchase Of Investment
-84.41
-81.15%
-46.59
+22.02%
-59.76
0.00
Sale Of Investment
82.09
+198.21%
27.53
+430.22%
5.19
-1.42%
5.27
Financing Cash Flow
-0.56
+62.77%
-1.51
+98.10%
-79.79
+60.02%
-199.58
Cash Flow From Continuing Financing Activities
-0.56
+62.77%
-1.51
+98.10%
-79.79
+60.02%
-199.58
Net Common Stock Issuance
-0.37
+55.86%
-0.84
+87.99%
-6.96
+94.56%
-127.96
Common Stock Payments
-0.37
+55.86%
-0.84
+87.99%
-6.96
+94.56%
-127.96
Common Stock Dividend Paid
-0.20
+72.73%
-0.71
+99.02%
-73.02
-1.95%
-71.62
Cash Dividends Paid
-0.20
+72.73%
-0.71
+99.02%
-73.02
-1.95%
-71.62
Repurchase Of Capital Stock
-0.37
+55.86%
-0.84
+87.99%
-6.96
+94.56%
-127.96
Proceeds From Stock Option Exercised
0.00
-100.00%
0.04
-80.85%
0.19
0.00
Changes In Cash
-1.63
+54.23%
-3.56
-152.18%
6.82
+141.53%
-16.43
Effect Of Exchange Rate Changes
0.00
-91.49%
0.05
+165.28%
-0.07
-7.46%
-0.07
Beginning Cash Position
90.93
-3.72%
94.44
+7.70%
87.69
-15.83%
104.18
End Cash Position
89.30
-1.79%
90.93
-3.72%
94.44
+7.70%
87.69
Free Cash Flow
1.25
-92.66%
17.02
-87.94%
141.17
-20.64%
177.89
Income Tax Paid Supplemental Data
10.46
—
34.26
-7.95%
37.21
Amortization Of Securities
-0.67
+16.02%
-0.80
-372.78%
-0.17
-1307.14%
0.01
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category